课题基金 / 基金详情

Association of human herpesvirus 6 (HHV-6) in hematological malignancies and vertical transmission of HHV-6 genome

Association of human herpesvirus 6 (HHV-6) in hematological malignancies and vertical transmission of HHV-6 genome
人类疱疹病毒 6 (HHV-6) 与血液恶性肿瘤的关联及 HHV-6 基因组的垂直传播
批准号:
11671002
负责人:
DAIBATA Masanori
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

DAIBATA Masanori的其他基金

相似基金

相关文献

中文摘要
翻译
1.在过去的15年里,三种新的人类肝炎病毒(HHV-6、HHV-7和HHV-8)被认为是几种人类疾病的病原体。HHV-6被认为是某些人类淋巴增生性疾病的可能原因或调节因素。我们发现了两例淋巴瘤,均携带染色体整合的HHV-6基因组。为了评估HHV-6DNA通过染色体传播的可能性,我们寻找了他们家族中的病毒基因组。在这两个病例中,在他们的后代中,在患者病毒整合的相同位置检测到HHV-6基因组。我们提出了一种新的HHV-6潜伏形式,其中整合的HHV-6基因组可以在染色体上遗传。2。(1)尽管HHV-6和HHV-7之间存在基因组同源性和血清学交叉反应,但HHV-7与淋巴增殖性疾病相关的证据一直很少。我们在淋巴细胞白血病患者中搜索了HHV-7基因组。入选患者61例,成人ALL 33例,儿童ALL 15例,CLL 13例。在所有样本中均未发现HHV-7基因组,提示HHV-7在淋巴细胞性白血病中可能起致病作用。(2)我们检测了14例原发眼MALT淋巴瘤患者标本中四种人类疱疹病毒(EBV、HHV-6、HHV-7和HHV-8)。4例标本经聚合酶链式反应检测出EB病毒DNA,其中4例HHV-6DNA阳性。HHV-7和HHV-8DNA均未检出。这些发现提示EBV和HHV-6可能参与了一组低度恶性原发眼淋巴瘤的发病机制。(3)在1例淋巴瘤患者发生的进行性多灶性白质脑病(PML)的脑部病变中检测到HHV-6基因组。众所周知,HHV-6在免疫抑制期间会重新激活,可能会导致几种致命的并发症。我们建议HHV-6与免疫受损宿主中PML的发病机制有关。
英文摘要
1. Over the past 15 years three new human hepesviruses (HHV-6, HHV-7 and HHV-8) have been recognized and implicated as eliological agents of several human diseases. HHV-6 has been cited as a possible cause or as a modulating element of certain human lymphoproliferative disorders. We found two cases of lymphoma and ALL carrying chromosomally integrated HHV-6 genomes. To assess the possibility of chromosomal transmission of HHV-6 DNA, we looked for the viral genome in their families. In both cases, the HHV-6 genomes were detected in their offspring at the identical sites of viral integration of the patients. We propose a novel latent form for HHV-6, in which integrated HHV-6 genome can be chromosomally inherited.2.(1) Despite the genomic homology, and serological cross-reactivity between HHV-6 and HHV-7, evidence for the association of HHV-7 with lymphoproliferative disorders has been scarce. We searched for the HHV-7 genome in patients with lymphocytic leukemia. Sixty-one patients were enrolled : 33 adult ALL ; 15 childhood ALL ; and 13 CLL. HHV-7 genome was not found in any of our samples, suggesting that HHV-7 is unlikely to play a pathogenetic role in lymphocytic leukemia.(2) We evaluated the presence of four human herpesviruses (EBV, HHV-6, HHV-7 and HHV-8) in the specimens from 14 patients with primary ocular MALT lymphoma. EBV DNA were detected in 4 samples by PCR, and 4 cases were positive for HHV-6DNA. Neither HHV-7 nor HHV-8DNA could by detected. These findings suggested the possible involvement of EBV and HHV-6 in the pathogenesis of a subset of low-grade primary ocular lymphomas.(3) HHV-6 genome was detected in the brain lesions of progressive multifocal leukoencephalopathy (PML) developing in a lymphoma patient. HHV-6 is known to be reactivated during immunosuppression and can cause several fatal complications. We propose an association of HHV-6 with the pathogenesis of PML in immunocompromised hosts.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
A.Hayakawa: "Genomic organization, tissue expression, and cellular localization of AF3p21, a fusion partner of MLL in therapy-related leukemia"Genes Chrom.Cancer. 30. 364-374 (2001)
A.Hayakawa:“AF3p21 的基因组组织、组织表达和细胞定位,AF3p21 是治疗相关白血病中 MLL 的融合伴侣”Genes Chrom.Cancer。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masanori Daibata: "Presence of human herpesvirus 6 DNA in cord blood cells."J Infect Dis. 179. 1046-1047 (1999)
Masanori Daibata:“脐带血细胞中存在人类疱疹病毒 6 DNA。”J Infect Dis。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
大畑雅典: "リンパ指向性ウイルスと造血器腫瘍"血液・腫瘍科. 41(2). 181-188 (2000)
Masanori Ohata:“嗜淋巴病毒和造血肿瘤”,血液学和肿瘤学 41(2) (2000)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Masanori Daibata: "Human herpesviruses in primary ocular lymphoma"Leukemia and Lymphoma. 37. 361-365 (2000)
Masanori Daibata:“原发性眼淋巴瘤中的人类疱疹病毒”白血病和淋巴瘤。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Oncogenesis of the infection- and chronic inflammatory-associated lymphomas and development of novel therapeutic strategy
    • 批准号:
      17K09927
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2017
    • 负责人:
      DAIBATA Masanori
    • 依托单位:
    Elucidation of molecular mechanism of hematological malignancies associated with persistent viral infection
    • 批准号:
      26461423
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2014
    • 负责人:
      DAIBATA Masanori
    • 依托单位:
    Pathogenesis of hematological malignancies caused by viral infection
    • 批准号:
      23591391
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      DAIBATA Masanori
    • 依托单位:
    Identification of a novel methylated gene as a prognostic factor in hematological malignancies and its clinical application.
    • 批准号:
      20591133
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2008
    • 负责人:
      DAIBATA Masanori
    • 依托单位:
    海外基金